ATE222802T1 - Verwendung von hydrophoben zeolithen, sprize und methode zur entfernung von konservierungsmitteln aus einer polypeptidlösung - Google Patents

Verwendung von hydrophoben zeolithen, sprize und methode zur entfernung von konservierungsmitteln aus einer polypeptidlösung

Info

Publication number
ATE222802T1
ATE222802T1 AT96935707T AT96935707T ATE222802T1 AT E222802 T1 ATE222802 T1 AT E222802T1 AT 96935707 T AT96935707 T AT 96935707T AT 96935707 T AT96935707 T AT 96935707T AT E222802 T1 ATE222802 T1 AT E222802T1
Authority
AT
Austria
Prior art keywords
solutions
pct
preservatives
syringe
removal
Prior art date
Application number
AT96935707T
Other languages
English (en)
Inventor
Sten Andersson
Hakan Eriksson
Kare Larsson
Original Assignee
Sten Andersson
Hakan Eriksson
Kare Larsson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sten Andersson, Hakan Eriksson, Kare Larsson filed Critical Sten Andersson
Application granted granted Critical
Publication of ATE222802T1 publication Critical patent/ATE222802T1/de

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
    • B01J20/10—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising silica or silicate
    • B01J20/16—Alumino-silicates
    • B01J20/18—Synthetic zeolitic molecular sieves
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2220/00—Aspects relating to sorbent materials
    • B01J2220/50—Aspects relating to the use of sorbent or filter aid materials
    • B01J2220/64—In a syringe, pipette, e.g. tip or in a tube, e.g. test-tube or u-shape tube

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Water Supply & Treatment (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
AT96935707T 1995-10-24 1996-10-15 Verwendung von hydrophoben zeolithen, sprize und methode zur entfernung von konservierungsmitteln aus einer polypeptidlösung ATE222802T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9503731A SE505274C2 (sv) 1995-10-24 1995-10-24 Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösning
PCT/SE1996/001306 WO1997015391A1 (en) 1995-10-24 1996-10-15 Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution

Publications (1)

Publication Number Publication Date
ATE222802T1 true ATE222802T1 (de) 2002-09-15

Family

ID=20399935

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96935707T ATE222802T1 (de) 1995-10-24 1996-10-15 Verwendung von hydrophoben zeolithen, sprize und methode zur entfernung von konservierungsmitteln aus einer polypeptidlösung

Country Status (9)

Country Link
US (1) US5936061A (de)
EP (1) EP0956155B1 (de)
JP (1) JPH11514920A (de)
AT (1) ATE222802T1 (de)
AU (1) AU693047B2 (de)
CA (1) CA2235767A1 (de)
DE (1) DE69623354T2 (de)
SE (1) SE505274C2 (de)
WO (1) WO1997015391A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802140D0 (sv) * 1998-06-16 1998-06-16 Ordio Ab Zeoliter för adsorption
SE9804029D0 (sv) * 1998-12-09 1998-12-09 Ordio Ab Adsorption av ftalater
US6589224B2 (en) * 2001-02-14 2003-07-08 Renal Tech International Llc Method of introducing fluids into a patient's body
US20050031708A1 (en) * 2003-08-06 2005-02-10 Portney Micah S. Composition comprising a zeolite compound for treatment of diseases
DE602007006282D1 (de) * 2006-02-24 2010-06-17 Novo Nordisk Healthcare Ag Verfahren zur entfernung eines nichtmetallischen proteinhemmers aus einer flüssigen pharmazeutischen zubereitung
CA2574746A1 (en) * 2007-01-22 2008-07-22 Duoject Medical Systems Inc. Syringe having venting structure and method for mixing two substances in a syringe
WO2009027478A2 (en) * 2007-08-29 2009-03-05 Novo Nordisk Health Care Ag A method of removing preservatives from a liquid pharmaceutical preparation
US10405961B2 (en) 2013-03-14 2019-09-10 Cell and Molecular Tissue Engineering, LLC Coated surgical mesh, and corresponding systems and methods
US10130288B2 (en) 2013-03-14 2018-11-20 Cell and Molecular Tissue Engineering, LLC Coated sensors, and corresponding systems and methods
CA2955964C (en) * 2014-08-13 2024-05-07 University Of Florida Research Foundation, Inc. Preservative removal from eye drops
WO2016196516A1 (en) 2015-06-03 2016-12-08 William Kenneth Ward Measurement of glucose in an insulin delivery catheter by minimizing the adverse effects of insulin preservatives
ES2959428T3 (es) * 2016-04-22 2024-02-26 Lilly Co Eli Dispositivo de infusión con componentes que comprenden un sorbente polimérico para reducir la concentración de m-cresol en la insulina
WO2018204327A1 (en) * 2017-05-01 2018-11-08 Becton, Dickinson And Company Filter for reducing phenolic compounds from insulin and related infusion and injection devices
JP7200134B2 (ja) 2017-06-08 2023-01-06 アムジエン・インコーポレーテツド トルク駆動式薬物送達デバイス
WO2019209644A1 (en) * 2018-04-27 2019-10-31 Becton, Dickinson And Company Delivery device and adsorbent
WO2019236653A1 (en) * 2018-06-06 2019-12-12 Entopsis Llc System and method for removing phenolic preservations from insulin formulations
CN115397374A (zh) 2019-12-19 2022-11-25 特清公司 从滴眼剂中去除防腐剂
EP4192405A4 (de) * 2020-08-05 2024-08-21 Tearclear Corp. Systeme und verfahren zur konservierungsstoffentfernung aus ophthalmischen formulierungen
JP7827704B2 (ja) 2020-08-23 2026-03-10 パシフィック・ダイアビーツ・テクノロジーズ・インコーポレイテッド インスリン保存剤の悪影響を最小限にすることによるインスリン送達カテーテル近傍でのグルコースの測定：代替配位子および酸化還元メディエーター金属
EP4543509A1 (de) * 2022-06-23 2025-04-30 Insulet Corporation Am körper tragbare arzneimittelabgabevorrichtung mit integrierter filtration

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4240986A (en) * 1979-02-23 1980-12-23 Uop Inc. Process for the separation of ortho-chloronitrobenzene
EP0021267B1 (de) * 1979-06-18 1982-06-16 PQ Corporation Agglomerierter Zeolith-Ionenaustauscher
SE8902919L (sv) * 1989-09-05 1991-03-05 Haakan Eriksson Anvaendning av zeoliter som adsorbenter av detergenter i biokemiska/biotekniska system och processer
SE9201976D0 (sv) * 1992-06-26 1992-06-26 Tektolit Ab Haakan Eriksson En metod foer att adsorbera proteiner och peptider till hydrofoba zeoliter
US5314855A (en) * 1992-11-09 1994-05-24 Akzo N.V. Adsorbent compositions and methods of manufacture
US5585007A (en) * 1994-12-07 1996-12-17 Plasmaseal Corporation Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant

Also Published As

Publication number Publication date
DE69623354T2 (de) 2003-01-09
CA2235767A1 (en) 1997-05-01
AU693047B2 (en) 1998-06-18
JPH11514920A (ja) 1999-12-21
SE9503731L (sv) 1997-04-25
AU7352496A (en) 1997-05-15
US5936061A (en) 1999-08-10
WO1997015391A1 (en) 1997-05-01
EP0956155B1 (de) 2002-08-28
SE9503731D0 (sv) 1995-10-24
SE505274C2 (sv) 1997-07-28
EP0956155A1 (de) 1999-11-17
DE69623354D1 (de) 2002-10-02

Similar Documents

Publication Publication Date Title
DE69623354D1 (de) Verwendung von hydrophoben zeolithen, sprize und methode zur entfernung von konservierungsmitteln aus einer polypeptidlösung
ES2563677T3 (es) Composiciones de combinaciones de Neisseria
RU94046367A (ru) Днк, хозяйская клетка, способ получения белка, белок, фармацевтический препарат, антитело, применение антитела
DE50004018D1 (de) Verwendung natriuretischer peptide als antibiotisch wirksame substanzen zur behandlung von bakteriellen infektionen
ATE451928T1 (de) Verfahren zur behandlung von krankheiten mit pflanzenextrakten
ZA91134B (en) New proteins produced by human lymphocytes,dna sequence encoding these proteins and their pharmaceutical and biological uses
BR9710452A (pt) Anïïlogos de exendina processos para sua prepara-Æo e medicamentos contendo os mesmos
DE69629042D1 (de) Polysulfon-membran zur reinigung von blut
DE69333286D1 (de) Eine thrombin-blutfraktion zur verwendung in einem medizinischen verfahren
DE69430990D1 (de) Zusammensetzung und methode zur anreicherung von weissen blutzellen aus menschlichem vollblut
EP2270040A3 (de) Polypeptide zur Bindung an das B-Lymphozyten-stimulatorische Protein (BLyS)
UA29421C2 (uk) Спосіб виділення фактора vііі з інших білків в плазмі крові
ATE188994T1 (de) Methoden zur trans-destabilisierung von spezifischen proteinen in vivo
DE69715414D1 (de) Stabilisierte pharmazeutische zusammensetzung von bdnf
DK610888A (da) Cardiodilatinfragmentet, fremgangsmaade til fremstilling deraf samt dets anvendelse
IL92937A0 (en) Human derived monocyte attracting protein,pharmaceutical compositions comprising it and dna encoding it
ATE211391T1 (de) Verwendung von hmg proteinen zur herstellung von arzneimitteln mit zytotoxischer wirkung
LTIP1753A (en) Dna sequences coding for proteins, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
FR2754737B1 (fr) Membrane inorganique de nanofiltration et son application dans l'industrie sucriere
DE59608804D1 (en) (s)-hydroxynitrillyase aus hevea brasiliensis
ATE512217T1 (de) 5-substituerte hydantoin racemase, dafür kodierende dna, und verfahren zur herstellung optisch aktiver aminosäure
DE69328102D1 (de) Verwendung von gift aus hautflüglern (hymenopteren) zur herstellung eines medikamentes zur behandlung von infektionen durch dna-viren
ATE215811T1 (de) Verfahren zur aminosäuregewinnung aus proteinen und verwendung derselben aminosäurehaltigen produkte
DK0616642T3 (da) Hidtil ukendte thrombininhibitoriske proteiner fra landblodigler
DE3685469D1 (de) Elastineprodukt, herstellungsverfahren und biologische anwendungen desselben, insbesondere als biomaterialien und kuenstliche traegerstoffe.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties